Fate Therapeutics, Inc.
FATE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$186 | -$161 | -$282 | -$212 |
| Dep. & Amort. | $19 | $18 | $14 | $6 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $54 |
| Change in WC | -$2 | $19 | -$35 | $2 |
| Other Non-Cash | $46 | -$9 | $54 | -$13 |
| Operating Cash Flow | -$123 | -$132 | -$248 | -$163 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$6 | -$36 | -$51 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$318 | -$359 | -$405 | -$968 |
| Inv. Sales/Matur. | $331 | $478 | $607 | $695 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $12 | $113 | $167 | -$324 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $95 | $0 | $9 | $412 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5 | $0 | $0 | $41 |
| Financing Cash Flow | $100 | $0 | $9 | $453 |
| Forex Effect | $5 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | -$19 | -$72 | -$34 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42 | $61 | $134 | $183 |
| End Cash | $36 | $42 | $61 | $149 |
| Free Cash Flow | -$124 | -$138 | -$284 | -$214 |